- Home
- AQST vs FFNW Comparison
AQST vs FFNW Comparison
Compare AQST & FFNW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AQST
- FFNW
- Stock Information
- Founded
- AQST 2004
- FFNW 1923
- Country
- AQST United States
- FFNW United States
- Employees
- AQST N/A
- FFNW N/A
- Industry
- AQST Biotechnology: Pharmaceutical Preparations
- FFNW Banks
- Sector
- AQST Health Care
- FFNW Finance
- Exchange
- AQST Nasdaq
- FFNW Nasdaq
- Market Cap
- AQST 254.1M
- FFNW 208.8M
- IPO Year
- AQST 2018
- FFNW N/A
- Fundamental
- Price
- AQST $2.51
- FFNW $22.84
- Analyst Decision
- AQST Strong Buy
- FFNW Hold
- Analyst Count
- AQST 6
- FFNW 2
- Target Price
- AQST $11.17
- FFNW $22.75
- AVG Volume (30 Days)
- AQST 1.4M
- FFNW 78.3K
- Earning Date
- AQST 05-06-2025
- FFNW 04-29-2025
- Dividend Yield
- AQST N/A
- FFNW 0.57%
- EPS Growth
- AQST N/A
- FFNW N/A
- EPS
- AQST N/A
- FFNW 0.12
- Revenue
- AQST $57,561,000.00
- FFNW $37,609,000.00
- Revenue This Year
- AQST N/A
- FFNW N/A
- Revenue Next Year
- AQST $39.51
- FFNW N/A
- P/E Ratio
- AQST N/A
- FFNW $195.85
- Revenue Growth
- AQST 13.79
- FFNW N/A
- 52 Week Low
- AQST $2.20
- FFNW $18.03
- 52 Week High
- AQST $5.80
- FFNW $23.50
- Technical
- Relative Strength Index (RSI)
- AQST 41.88
- FFNW 64.00
- Support Level
- AQST $2.20
- FFNW $22.32
- Resistance Level
- AQST $2.61
- FFNW $23.05
- Average True Range (ATR)
- AQST 0.22
- FFNW 0.28
- MACD
- AQST -0.03
- FFNW -0.02
- Stochastic Oscillator
- AQST 36.47
- FFNW 73.08
About AQST Aquestive Therapeutics Inc.
Aquestive Therapeutics Inc is a specialty pharmaceutical company engaged in developing and commercializing differentiated products to meet medical needs. Its later-stage product pipeline focuses on the treatment of diseases of the Central Nervous System (CNS), and an earlier-stage pipeline for the treatment of severe allergic reactions, including anaphylaxis. Its commercial product portfolio includes Suboxone, Emylif, Ondif and Sympazan. The product pipeline includes Libervant Buccal Film, AQST-108. The majority of its revenue comes from the United States.
About FFNW First Financial Northwest Inc.
First Financial Northwest Inc is the holding company. The Bank's business consists predominantly of attracting deposits from the general public, combined with borrowing from the FHLB of Des Moines and raising funds in the wholesale market then utilizing these funds to originate one-to-four family residential, multifamily, commercial real estate, construction/land, business, and consumer loans. The Bank's strategic initiatives seek to diversify its loan portfolio and broaden growth opportunities with its current risk tolerance levels and asset/liability objectives.